Literature DB >> 11227668

Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication.

H Miki1, S Kobayashi, H Harada, Y Yamanoi, T Uraoka, M Sotozono, M Ohmori.   

Abstract

A 68-year-old woman was diagnosed with gastric lymphoma of the mucosa-associated lymphoid tissue (MALT) type with a high-grade component. Surgical treatment was recommended because of the presence of the high-grade component, but she refused surgery. As an alternative, she received Helicobacter pylori eradication treatment, which successfully induced regression of the lymphoma. She shows no sign of recurrence endoscopically and histologically, as of 29 months after the eradication treatment. Moreover, the B-cell monoclonality and Helicobacter pylori infection demonstrated at diagnosis has disappeared. This is one of the rare cases of gastric lymphoma of the MALT type with a high-grade component cured by Helicobacter pylori eradication alone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11227668     DOI: 10.1007/s005350170140

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  4 in total

Review 1.  Long-term follow-up of gastric MALT lymphoma after H. pylori eradication.

Authors:  A Morgner; C Thiede; E Bayerdörffer; B Alpen; T Wündisch; A Neubauer; M Stolte
Journal:  Curr Gastroenterol Rep       Date:  2001-12

2.  Molecular pathology of primary intraocular lymphoma.

Authors:  Chi-Chao Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2003

3.  Clinicopathologic study of mucosa-associated lymphoid tissue lymphoma in gastroscopic biopsy.

Authors:  Hong Cheng; Jun Wang; Chuan-Shan Zhang; Pei-Song Yan; Xiao-Hui Zhang; Pei-Zhen Hu; Fu-Cheng Ma
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

Review 4.  High grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature.

Authors:  Luigi Cavanna; Raffaella Pagani; Pietro Seghini; Adriano Zangrandi; Carlo Paties
Journal:  World J Surg Oncol       Date:  2008-03-19       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.